Bianchi, S., Martínez Allo, V. C., Massimino, M., Lavignolle Heguy, M. d. R., Borzone, F. R., Gomez Bustillo, S., . . . Bianchi, M. S. (2021). Oligonucleotide IMT504 Improves Glucose Metabolism and Controls Immune Cell Mediators in Female Diabetic NOD Mice. Nucleic Acid Therapeutics, 31(2), 155. https://doi.org/10.1089/nat.2020.0901
Chicago Style (17th ed.) CitationBianchi, Stefania, et al. "Oligonucleotide IMT504 Improves Glucose Metabolism and Controls Immune Cell Mediators in Female Diabetic NOD Mice." Nucleic Acid Therapeutics 31, no. 2 (2021): 155. https://doi.org/10.1089/nat.2020.0901.
MLA (9th ed.) CitationBianchi, Stefania, et al. "Oligonucleotide IMT504 Improves Glucose Metabolism and Controls Immune Cell Mediators in Female Diabetic NOD Mice." Nucleic Acid Therapeutics, vol. 31, no. 2, 2021, p. 155, https://doi.org/10.1089/nat.2020.0901.